APA (7th ed.) Citation

Jonušaitė, I., Giedraitienė, N., Kaubrys, G., & Kizlaitienė, R. The Role of the New Anti-CD20 Monoclonal Antibodies in Active Relapsing – Remitting Multiple Sclerosis Treatment: Efficacy and Safety of ofatumumab. Vilnius University Press.

Chicago Style (17th ed.) Citation

Jonušaitė, I., N. Giedraitienė, G. Kaubrys, and R. Kizlaitienė. The Role of the New Anti-CD20 Monoclonal Antibodies in Active Relapsing – Remitting Multiple Sclerosis Treatment: Efficacy and Safety of Ofatumumab. Vilnius University Press.

MLA (9th ed.) Citation

Jonušaitė, I., et al. The Role of the New Anti-CD20 Monoclonal Antibodies in Active Relapsing – Remitting Multiple Sclerosis Treatment: Efficacy and Safety of Ofatumumab. Vilnius University Press.